Efficacy and safety of calcium channel blockers in heart failure: Focus on recent trials with second-generation dihydropyridines-Reference-Cited by-同舟云学术

Efficacy and safety of calcium channel blockers in heart failure: Focus on recent trials with second-generation dihydropyridines

Published:2000-02 Issue:2 Volume:139 Page:185-194
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

de Vries Rob J.M,van Veldhuisen Dirk J,Dunselman Peter H.J.M

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference54 articles.

1. Current medical therapy for advanced heart failure;Gheorghiade;Am Heart J,1998

2. Improved diastolic function with the calcium antagonist nisoldipine (coat-core) in patients post-myocardial infarction: results of the DEFIANT study;Eur Heart J,1992

3. A controlled clinical trial to assess the effect of a calcium blocker on the progression of coronary atherosclerosis;Waters;Circulation,1990

4. Shanghai trial of nifedipine in the elderly (STONE);Gong;J Hypertens,1996

5. The neurohumoral hypothesis: a theory to explain the mechanism of disease progression in heart failure;Packer;J Am Coll Cardiol,1992

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective blockade of Cav1.2 (α1C) versus Cav1.3 (α1D) L-type calcium channels by the black mamba toxin calciseptine;Nature Communications;2024-01-02

2. Development of a list of potentially inappropriate medications for patients with heart failure (PIMHF);Research in Social and Administrative Pharmacy;2021-05

3. Membrane Proteins | L-Type Calcium Channels in Health and Disease: The Case of Heart Failure;Encyclopedia of Biological Chemistry III;2021

4. Electron paramagnetic resonance study of gamma induced free radicals in single crystal of 1-[2-(1-ethoxy-carbonyl-3-phenylpropylamino)propionyl]octahydrocylo-penta[b]pyrrole-2-carboxylic acid;Journal of Molecular Structure;2020-03

5. Y-27632 preconditioning enhances transplantation of human-induced pluripotent stem cell-derived cardiomyocytes in myocardial infarction mice;Cardiovascular Research;2018-08-13